Amend Surgical Receives Funding for Suture-less Nerve Repair Device
Amend Surgical, Inc., a UF Innovate | Accelerate client, has been awarded substantial product development funding from The Michigan-Pittsburgh-Wyss Regenerative Medicine (MPWRM) Resource Center to commercialize a novel, suture-less solution for the repair of peripheral nerves. Tissure is a resorbable hydrogel membrane with a chitosan-based adhesive that has the adhesion and mechanical strength to potentially replace sutures for the repair of peripheral nerve injuries.
IdentifySensors Adds Four Regulatory and Quality Experts To Move New Technology to Commercialization
UF Innovate client's, IdentifySensors® Biologics, a leading developer of digital diagnostic technologies, has named four new industry specialists in regulatory, quality and supply chain to oversee good manufacturing and FDA submissions for the company's Check4® digital diagnostics platform product pipeline.
Amend Surgical Unveils Tough Adhesive Hydrogel for Intraoral Adhesion and Drug Delivery
In a groundbreaking development, Amend Surgical has announced the first-ever publication on the use of its Amend Tissue Tape, also known as DenTAI, in an oral application. The company is thrilled to report that the results have exceeded expectations and validated the extensive research and development that has gone into this revolutionary product platform. This exciting news paves the way for Amend Surgical to bring its transformative product to the market next year.
Glint Pharmaceuticals Receives FDA IND Acceptance for Clinical Study for Phase 1/2 Clinical Trial of Antibiotic Drug-Releasing Contact Lens, ACL5
UF startup Glint Pharmaceuticals (Glint), a clinical-stage biotechnology company focused on developing a next-generation contact lens drug delivery technology, announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application to evaluate its antibiotic drug delivery contact lens, ACL5. Glint anticipates beginning the investigation in Q2 2023.
Florida Tech Corridor Reaches for the Future
They’re among hundreds of innovations powered by the Florida High Tech Corridor, an initiative anchored by a trio of Florida research universities that rings Sumter County. Just marking its 27th anniversary, leaders of Florida’s tech triangle —UF in Gainesville, UCF in Orlando and USF in Tampa — say the future will bring even more revolution.
A Founder’s Collaboration Skills May Be the Key to Success, Especially in Deep Tech
Accelerators like UF Innovate are crucial to the early-stage economy, and to innovation in the United States. It’s at places like these that new technologies can be brought to the market, including technologies that with a profound effect on people’s lives and health. One UF Innovate company, for instance, is MYOLYN, which makes therapy systems for people with neurological disorders and injuries, like multiple sclerosis or stroke.
Using Whole-Genome Sequencing To Study Early-Onset Parkinson’s Disease
The Norwegian term for virgin snow, “nysnø”, seemed the appropriate inspiration to name Jennifer Johnston’s company, NysnoBio, as it underscores the pioneering work NysnoBio is doing to tap the potential of Parkin, the protein most often linked to young onset genetic Parkinson’s disease.
Startup Spotlight: Slice Engineering
Imagine 3D printing a body part for a major organ transplant surgery to save a person’s life. The backgrounds of both co-founders, Daniel Barousse and Chris Montgomery, have been influenced by this incredible technology. Their curiosity and insights into creating a better and more dynamic 3D printing experience for their clients were the geneses of UF Innovate | Accelerate client resident, Slice Engineering.
Biogen and Alcyone Therapeutics Announce License and Collaboration Agreement To Evaluate a Novel Device To Improve Patient Experience and Access to Neurological Aso Therapies
Biogen Inc. and Alcyone Therapeutics have entered into a license and collaboration agreement to develop Alcyone’s ThecaFlex DRxTM System, an implantable medical device intended for subcutaneous delivery of antisense oligonucleotide (ASO) therapies into the intrathecal space. Through this agreement, Biogen aims to leverage the ThecaFlex DRxTM System with a goal of improving the patient treatment experience and accessibility for a broader population of people suffering from neurological disorders, such as spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS).
Satellite-Mounted Telescopes Get a New Focus: Earth
With Garmendia leading the way, UF, the State of Florida and the Spanish government developed a plan for a $10 million collaboration to develop small satellite telescopes to look for dark matter, and to conduct Earth observations. Over the next several years — with support from UF Research, the Florida Space Research Institute (now Space Florida), and the Florida High Tech Corridor Council — Guzmán and the Satlantis team based at UF Innovate’s The Hub in downtown Gainesville worked with astronomy department engineers on the new telescope.
